Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 1, 2005

Plasma Total Antioxidant Capacity in Hemodialyzed Patients and Its Relationships to other Biomarkers of Oxidative Stress and Lipid Peroxidation

  • GianMario Gerardi , Mario Usberti , Giuliana Martini , Alberto Albertini , Lidia Sugherini , Alfonso Pompella and Diego Di Lorenzo

Abstract

Patients undergoing long-term hemodialysis (HD) exhibit increased levels of oxidative stress, likely contributing to the increased rate of cardiovascular disease. The present study represents a critical evaluation of some of the most widely used oxidative indicators, as applied to the monitoring of hemodialysis-associated oxidative stress.

Total plasma antioxidant capacity was determined by two independent procedures, the total antioxidant status (TAS) and the ferric reducing ability of plasma (FRAP) methods. Plasma lipid peroxidation was assessed by determining the peroxidation products malonaldehyde and 4-hydroxynonenal (MDA-4HNE) as well as lipid hydroperoxides (“Fox-2” and “d-ROMs” methods). Total plasma thiols and plasma b-tocopherol were also determined.

MDA-4HNE levels were higher in HD patients and decreased following HD, possibly due to passive diffusion across dialysis filters. d-ROMs were also higher in HD patients but exhibited a further increase following the dialysis procedure. Serum α-tocopherol did not show any significant differences. Plasma thiols were lower in HD patients and were restored following HD. Plasma total antioxidant capacity determined with either method was unexpectedly higher in HD patients compared to controls, and decreased following HD.

These data indicate that, of the biomarkers studied, d-ROMs level is the one more accurately reflecting the oxidative alterations taking place in HD patients, while determination of MDA-4HNE fails to detect oxidation occurring during the HD sessions. In addition, our findings point out that the determination of total antioxidant capacity in HD patients is severely affected by the concomitant fluctuations in plasma urate levels and therefore needs careful interpretation.

:
Published Online: 2005-06-01
Published in Print: 2002-03-01

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Downloaded on 28.3.2024 from https://www.degruyter.com/document/doi/10.1515/CCLM.2002.019/html
Scroll to top button